Blood-brain barrier (BBB) evidence

Peptide

Measured material

Peptide backbone

Endpoint

ADMET domain

Distribution / Barrier

Value

Observation

in_vitro_result: 35% fluoroscence measured at 1 micromolar peptide concentration; transport_type: Transcytosis

Measurement type

Relative / unspecified — Relative or source-reported value with no specified BBB metric type; not comparable across rows.

Evidence role

Reported: reviewed reported observation that should not be pooled as a comparable value yet

Assay / model

Human glioblastoma cell line U-87 · NA · blood-brain barrier

Condition

Route: NA · Transcytosis

Scientific source

DOI: 10.2147/IJN.S77734

Source: B3Pdb

Developability